Published in Drug Resist Updat on January 01, 1998
Overexpression of the alpha-2,6-sialyltransferase in MDCK cells increases influenza virus sensitivity to neuraminidase inhibitors. J Virol (2003) 5.11
Mechanism by which mutations at his274 alter sensitivity of influenza a virus n1 neuraminidase to oseltamivir carboxylate and zanamivir. Antimicrob Agents Chemother (2002) 2.20
Treatment of influenza with neuraminidase inhibitors: virological implications. Philos Trans R Soc Lond B Biol Sci (2001) 1.52
Potential risks associated with the proposed widespread use of Tamiflu. Environ Health Perspect (2007) 1.39
Direct measurement of the anti-influenza agent zanamivir in the respiratory tract following inhalation. Antimicrob Agents Chemother (2000) 1.11
Influenza AH1N2 viruses, United Kingdom, 2001-02 influenza season. Emerg Infect Dis (2003) 1.10
Loss of the N-linked glycan at residue 173 of human parainfluenza virus type 1 hemagglutinin-neuraminidase exposes a second receptor-binding site. J Virol (2008) 0.97
Broad-spectrum antiviral activity of Virazole: 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide. Science (1972) 7.74
Mechanism of action of 1- -D-ribofuranosyl-1,2,4-triazole-3-carboxamide (Virazole), a new broad-spectrum antiviral agent. Proc Natl Acad Sci U S A (1973) 4.36
Design, synthesis, and broad spectrum antiviral activity of 1- -D-ribofuranosyl-1,2,4-triazole-3-carboxamide and related nucleosides. J Med Chem (1972) 4.12
In vitro effect of 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide (virazole, ICN 1229) on deoxyribonucleic acid and ribonucleic acid viruses. Antimicrob Agents Chemother (1973) 4.04
Use of disposable micro tissue culture plates for antiviral and interferon induction studies. Appl Microbiol (1971) 2.85
Oral administration of a prodrug of the influenza virus neuraminidase inhibitor GS 4071 protects mice and ferrets against influenza infection. Antimicrob Agents Chemother (1998) 2.44
Characterization of human influenza virus variants selected in vitro in the presence of the neuraminidase inhibitor GS 4071. Antimicrob Agents Chemother (1998) 2.19
Chronic Cryptosporidium parvum infections in congenitally immunodeficient SCID and nude mice. J Infect Dis (1991) 2.15
Cyclopentane neuraminidase inhibitors with potent in vitro anti-influenza virus activities. Antimicrob Agents Chemother (2001) 1.89
Suppression by 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide (virazole, ICN 1229) of influenza virus-induced infections in mice. Antimicrob Agents Chemother (1973) 1.87
In vivo antiviral properties of biologically active compounds. II. Studies with influenza and vaccinia viruses. Appl Microbiol (1968) 1.76
Quantitative studies on fabrics as disseminators of viruses. I. Persistence of vaccinia virus on cotton and wool fabrics. Appl Microbiol (1966) 1.72
Quantitative studies on fabrics as disseminators of viruses. II. Persistence of poliomyelitis virus on cotton and wool fabrics. Appl Microbiol (1966) 1.55
Effects of cidofovir on the pathogenesis of a lethal vaccinia virus respiratory infection in mice. Antiviral Res (2001) 1.50
Treatment of lethal vaccinia virus respiratory infections in mice with cidofovir. Antivir Chem Chemother (2001) 1.43
Effect of 1-beta-D-ribofuranosyl1-1,2,4-triazole-3-carboxamide (virazole, ICN 1229) on herpes and vaccinia keratitis and encephalitis in laboratory animals. Antimicrob Agents Chemother (1973) 1.42
Defective corticogenesis and reduction in Reelin immunoreactivity in cortex and hippocampus of prenatally infected neonatal mice. Mol Psychiatry (1999) 1.35
Target-organ treatment of neurotropic virus diseases: efficacy as a chemotherapy tool and comparison of activity of adenine arabinoside, cytosine arabinoside, idoxuridine, and trifluorothymidine. Antimicrob Agents Chemother (1972) 1.32
Intranasal treatment of cowpox virus respiratory infections in mice with cidofovir. Antiviral Res (2000) 1.30
Prenatal viral infection in mouse causes differential expression of genes in brains of mouse progeny: a potential animal model for schizophrenia and autism. Synapse (2005) 1.26
Effect of selenazofurin on influenza A and B virus infections of mice. Antiviral Res (1986) 1.25
Ribavirin: an antiviral agent. Pharmacol Ther (1979) 1.16
Inhibition of RNA virus replication in vitro by 3-deazacytidine and 3-deazauridine. Proc Soc Exp Biol Med (1972) 1.16
Purine analogs as potential anticytomegalovirus agents. Proc Soc Exp Biol Med (1969) 1.15
Procedure for the evaluation of the virucidal effectiveness of an ethylene oxide gas sterilizer. Appl Microbiol (1969) 1.14
Quantitative studies on fabrics as disseminators of viruses. 3. Persistence of vaccinia virus on fabrics impregnated with a virucidal agent. Appl Microbiol (1967) 1.13
Effect of ribavirin on viral hepatitis in laboratory animals. Ann N Y Acad Sci (1977) 1.07
Treatment of murine cytomegalovirus infections in severe combined immunodeficient mice with ganciclovir, (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]cytosine, interferon, and bropirimine. Antimicrob Agents Chemother (1992) 1.07
In vitro activity of expanded-spectrum pyridazinyl oxime ethers related to pirodavir: novel capsid-binding inhibitors with potent antipicornavirus activity. Antimicrob Agents Chemother (2004) 1.05
Treatment of lethal Pichinde virus infections in weanling LVG/Lak hamsters with ribavirin, ribamidine, selenazofurin, and ampligen. Antiviral Res (1993) 1.05
Quantitative studies on fabrics as disseminators of viruses. V. Effect of laundering on poliovirus-contaminated fabrics. Appl Microbiol (1971) 1.05
Inhibition of rotaviruses by selected antiviral substances: mechanisms of viral inhibition and in vivo activity. Antimicrob Agents Chemother (1982) 1.01
Potentially infectious agents associated with shearling bedpads. I. Effect of laundering with detergent-disinfectant combinations on polio and vaccinia viruses. Appl Microbiol (1970) 1.01
Efficacy of 9-beta-D-arabinofuranosylhypoxanthine 5'-monophosphate in therapy of equine abortion virus-induced hepatitis in hamsters. Antimicrob Agents Chemother (1975) 1.01
Antiviral activity of 3-deazaguanine, 3-deazaguanosine, and 3-deazaguanylic acid. Antimicrob Agents Chemother (1977) 1.00
Cryptosporidial infections in SCID mice reconstituted with human or murine lymphocytes. J Protozool (1992) 1.00
Human influenza viral infection in utero alters glial fibrillary acidic protein immunoreactivity in the developing brains of neonatal mice. Mol Psychiatry (2002) 0.99
Utilization of transgenic mice replicating high levels of hepatitis B virus for antiviral evaluation of lamivudine. Antiviral Res (1999) 0.99
Pharmacodynamic evaluation of RWJ-270201, a novel neuraminidase inhibitor, in a lethal murine model of influenza predicts efficacy for once-daily dosing. Antimicrob Agents Chemother (2001) 0.99
Antiviral mechanisms of action. Annu Rev Pharmacol Toxicol (1980) 0.99
Antiviral activity of 9-beta-D-arabinofuranosyladenine. II. Activity against Herpes simplex keratitis in hamsters. Antimicrob Agents Chemother (Bethesda) (1968) 0.99
Synthesis and antiviral activity of certain 5'-monophosphates of 9-D-arabinofuranosyladenine and 9-D-arabinofuranosylhypoxanthine. J Med Chem (1975) 0.99
Effect of 9-beta-D-arabinofuranosylhypoxanthine 5'-monophosphate on genital lesions and encephalitis induced by Herpesvirus hominis type 2 in female mice. J Infect Dis (1976) 0.98
Treatment of cowpox virus respiratory infections in mice with ribavirin as a single agent or followed sequentially by cidofovir. Antivir Chem Chemother (2000) 0.98
Antiviral activity of 9-beta-D-arabinofuranosyladenine. V. Activity against intracerebral Vaccinia virus infections in mice. Antimicrob Agents Chemother (Bethesda) (1968) 0.98
Synthesis and antiviral activity of 1,2,4-triazole-3-thiocarboxamide and 1,2,4-triazole-3-carboxamidine ribonucleosides. J Med Chem (1973) 0.98
Heterocyclic thiosemicarbazones: correlation between structure, inhibition of ribonucleotide reductase, and inhibition of DNA viruses. Proc Soc Exp Biol Med (1970) 0.97
Transgenic mice as a chemotherapeutic model for hepatitis B virus infection. Antivir Ther (1998) 0.95
Bioassay system for determining ribavirin levels in human serum and urine. Chemotherapy (1981) 0.95
Antiviral activities of nucleosides and nucleotides against wild-type and drug-resistant strains of murine cytomegalovirus. Antiviral Res (1995) 0.94
Evaluation of the antiviral activity of anthraquinones, anthrones and anthraquinone derivatives against human cytomegalovirus. Antiviral Res (1992) 0.94
Studies of latent Q fever infections. 3. Effects of parturition upon latently infected guinea pigs and white mice. Am J Epidemiol (1966) 0.93
Selective inhibition of cytomegaloviruses by 9-(3'-ethylphosphono-1'-hydroxymethyl-1'-propyloxy-methyl)g uanine. Antiviral Res (1993) 0.93
Anti-DNA virus activity of the 5'-nucleotide and 3',5'-cyclic nucleotide of 9-beta-D-arabinofuranosyladenine. Chemotherapy (1973) 0.93
Herpes simplex keratitis in hamsters as a system for evaluating potential antiviral agents. Antimicrob Agents Chemother (Bethesda) (1966) 0.93
In vivo anti-influenza virus activity of a zinc finger peptide. Antimicrob Agents Chemother (1997) 0.93
Synthesis and antiviral and enzymatic studies of certain 3-deazaguanines and their imidazolecarboxamide precursors. J Med Chem (1978) 0.92
Mode of inhibition of respiratory syncytial virus by a plant flavonoid, SP-303. Chemotherapy (1993) 0.92
Inhibition of measles virus replication by 5'-nor carbocyclic adenosine analogues. Antivir Chem Chemother (2001) 0.92
In vitro studies on the antiviral activity of 1, 3-bis(2-chloroethyl)-1-nitrosourea. Appl Microbiol (1966) 0.91
Azapurine nucleosides. 2. Synthesis and antiviral activity of 7-amino-3- -D-arabinofuranosyl-v-triazolo (4,5-d)pyrimidine and related nucleosides. J Med Chem (1972) 0.91
In vivo activation of human immunodeficiency virus type 1 long terminal repeat by UV type A (UV-A) light plus psoralen and UV-B light in the skin of transgenic mice. J Virol (1991) 0.91
Synthesis and antiviral activity of certain thiazole C-nucleosides. J Med Chem (1977) 0.90
Inhibition of bluetongue and Colorado tick fever orbiviruses by selected antiviral substances. Antimicrob Agents Chemother (1981) 0.90
Effect of 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide (ribavirin) on Friend leukemia virus infections in mice. Proc Soc Exp Biol Med (1975) 0.90
Prophylactic and therapeutic activities of 7-thia-8-oxoguanosine against Punta Toro virus infections in mice. Antiviral Res (1991) 0.89
Potent inhibition of respiratory syncytial virus by polyoxometalates of several structural classes. Antiviral Res (1997) 0.89
Role of virucides in controlling virus dissemination by fabrics. J Am Oil Chem Soc (1969) 0.88
Progressive murine cytomegalovirus disease after termination of ganciclovir therapy in mice immunosuppressed by cyclophosphamide treatment. J Infect Dis (1991) 0.88
Synthesis and antiviral acticity of some phosphates of the broad-spectrum antiviral nucleoside, 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide (ribavirin). J Med Chem (1978) 0.87
Activity of selenazofurin against influenza A and B viruses in vitro. Antimicrob Agents Chemother (1985) 0.87
Anti-human cytomegalovirus activity and toxicity of sulfonated anthraquinones and anthraquinone derivatives. Antiviral Res (1995) 0.86
Failure of 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide (virazole, ICN 1229) to stimllate interferon. Antimicrob Agents Chemother (1973) 0.85
Comparison of the development of resistant strains of Type 1 herpes simplex virus to in vitro antiviral activity of 5-iodo-2'-deoxyuridine or ribavirin. Ann N Y Acad Sci (1977) 0.85
Immunological effects of the orally administered neuraminidase inhibitor oseltamivir in influenza virus-infected and uninfected mice. Immunopharmacology (2000) 0.85
Enantiomeric synthesis of D- and L-cyclopentenyl nucleosides and their antiviral activity against HIV and West Nile virus. J Med Chem (2001) 0.85
Characterization of an influenza A (H3N2) virus resistant to the cyclopentane neuraminidase inhibitor RWJ-270201. Antiviral Res (2001) 0.85
Synthesis and anti-deoxyribonucleic acid virus activity of certain 9-beta-D-arabinofuranosyl-2-substituted adenine derivatives. J Med Chem (1974) 0.84
Prenatal viral infection causes alterations in nNOS expression in developing mouse brains. Neuroreport (2000) 0.84
Experimental studies with four species of Brucella in selected wildlife, laboratory, and domestic animals. Am J Trop Med Hyg (1967) 0.83
In vitro and in vivo effect of 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide (ribavirin) on types 1 and 3 parainfulenza virus infections. Chemotherapy (1975) 0.83
Antiviral activities of tragacanthin polysaccharides on Punta Toro virus infections in mice. Chemotherapy (1997) 0.83
Activation of the human immunodeficiency virus type 1 long terminal repeat by skin-sensitizing chemicals in transgenic mice. Intervirology (1993) 0.83
In vitro effect of a variety of biologically active compounds on human cytomegalovirus. Chemotherapy (1972) 0.82
HIV-1 LTR activation model: evaluation of various agents in skin of transgenic mice. J Acquir Immune Defic Syndr (1992) 0.82
Antiherpesvirus activity and mode of action of SP-303, a novel plant flavonoid. Chemotherapy (1993) 0.81
Influence of malnutrition and alterations in dietary protein on murine rotaviral disease. Proc Soc Exp Biol Med (1983) 0.81
Quantitative studies on fabrics as disseminators of viruses. IV. Virus transmission by dry contact of fabrics. Appl Microbiol (1970) 0.81
In vitro antiviral activity of 6-substituted 9-beta-D-ribofuranosylpurine 3', 5'-cyclic phosphates. Antimicrob Agents Chemother (1974) 0.81
Viral keratitis-inhibitory effect of 9-beta-D-arabinofuranosylhypoxanthine 5'-monophosphate. Antimicrob Agents Chemother (1975) 0.81
Synthesis and biological activity of 9-beta-D-arabinofuranosyladenine cyclic 3',5'-phosphate and 9-beta-D-arabinofuranosylguanine cyclic 3',5'-phosphate. J Med Chem (1974) 0.81
Development of antiviral levels of ribavirin in serum and urine of orally treated rats. Chemotherapy (1981) 0.80
Inhibition of experimental deoxyribonucleic acid virus-induced encephalitis by 9-beta-D-arabinofuranosylhypoxanthine 5'-monophosphate. Antimicrob Agents Chemother (1975) 0.80
2-5A-DNA conjugate inhibition of respiratory syncytial virus replication: effects of oligonucleotide structure modifications and RNA target site selection. Antiviral Res (1999) 0.79
Effects of a series of purine analogs on Friend leukemia virus infections in mice. Cancer Res (1968) 0.79
Selective cytotoxicity towards cytomegalovirus-infected cells by immunotoxins consisting of gelonin linked to anti-cytomegalovirus antibody. Antiviral Res (1995) 0.79
Antiviral immunotoxins: antibody-mediated delivery of gelonin inhibits Pichinde virus replication in vitro. Antiviral Res (1991) 0.79
Lack of suppression of resistance factors to influenza infections in mice pretreated with virazole. J Antimicrob Chemother (1977) 0.78
DNA virus inhibitory activity of 1- -D-arabinofuranosylcytosine-3',5'-cyclic phosphate. Nat New Biol (1973) 0.78
Early-initiated zidovudine therapy prevents disease but not low levels of persistent retrovirus in mice. J Acquir Immune Defic Syndr (1991) 0.78